Matches in Wikidata for { <http://www.wikidata.org/entity/Q83066402> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q83066402 description "artículu científicu espublizáu en marzu de 2010" @default.
- Q83066402 description "im März 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83066402 description "scientific article published on 01 March 2010" @default.
- Q83066402 description "wetenschappelijk artikel" @default.
- Q83066402 description "наукова стаття, опублікована в березні 2010" @default.
- Q83066402 name "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 name "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 type Item @default.
- Q83066402 label "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 label "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 prefLabel "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 prefLabel "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 P1433 Q83066402-BECDA65C-4F0A-4F8A-BBD7-5AB7D8A6A6B4 @default.
- Q83066402 P1476 Q83066402-DA18ACF8-85BE-43EC-A04B-86BDD8645FAD @default.
- Q83066402 P2093 Q83066402-51250920-99E3-407B-A6E9-7B89561E6DE3 @default.
- Q83066402 P2093 Q83066402-5495598F-BD1E-455F-AB3A-EA9CCD3BAF99 @default.
- Q83066402 P304 Q83066402-F169A891-7D07-4D19-917C-132321A8830C @default.
- Q83066402 P31 Q83066402-04AFB28F-5AF9-46F3-A002-7AD8FC94B19D @default.
- Q83066402 P356 Q83066402-371C8E68-C59A-4566-A6EF-3D5D5B5715D5 @default.
- Q83066402 P433 Q83066402-C48709F1-A0A5-4601-8E2E-DE070C6E07FC @default.
- Q83066402 P478 Q83066402-F6E55283-9725-40DC-A857-474C4C0020CF @default.
- Q83066402 P577 Q83066402-0BAB32A7-E55E-40CB-92CA-38A97225E438 @default.
- Q83066402 P698 Q83066402-C78A59A2-0813-4123-829B-CAF6FDDDAF3C @default.
- Q83066402 P921 Q83066402-8BD9BA94-80B7-432E-BAAF-88B8A70FE128 @default.
- Q83066402 P356 J.AJIC.2009.09.010 @default.
- Q83066402 P698 20189684 @default.
- Q83066402 P1433 Q15767042 @default.
- Q83066402 P1476 "Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device" @default.
- Q83066402 P2093 "Charles E Edmiston" @default.
- Q83066402 P2093 "Vera Markina" @default.
- Q83066402 P304 "421-423" @default.
- Q83066402 P31 Q13442814 @default.
- Q83066402 P356 "10.1016/J.AJIC.2009.09.010" @default.
- Q83066402 P433 "6" @default.
- Q83066402 P478 "38" @default.
- Q83066402 P577 "2010-03-01T00:00:00Z" @default.
- Q83066402 P698 "20189684" @default.
- Q83066402 P921 Q11468 @default.